Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Light application
Reexamination Certificate
2002-04-09
2004-07-20
Peffley, Michael (Department: 3739)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Light application
C607S094000, C607S088000, C606S003000
Reexamination Certificate
active
06764501
ABSTRACT:
FIELD OF THE INVENTION
This invention relates to an apparatus and method for treating atherosclerotic vascular disease by means of light radiation.
BACKGROUND OF THE INVENTION
Atherosclerotic vascular disease represents one of the major health problems in the world. It is the number one cause of death in the United States, being responsible for one third of all reported mortality on an annual basis. The magnitude of the problem is staggering; in the United States alone over 60 million people have some form of atherosclerotic vascular disease. In 1995, approximately 1,000,000 people died from this problem. Atherosclerotic vascular disease ranks as the leading reason for social security disability, limitation in physical activity, and hospital bed use accounting for 46 million bed days in 1994. The direct and indirect costs of treating this scourge is in the hundreds of billions of dollars on an annual basis.
Although research in this area has been intense, the exact cause of atherosclerotic artery disease remains unknown. Atherosclerosis is the descriptive term for thickened and hardened lesions of the arteries. It results from fatty deposits that build up in the innermost lining, or intima, of the artery. The lesions are generally eccentric and if they become sufficiently large, can occlude the artery and thus the blood supply to a tissue or organ, resulting in ischemia or necrosis. If this occurs, it often leads to the characteristic clinical outcomes of myocardial infarction (heart attack), cerebral infarction (stroke), gangrene of the extremities, etc.
The exact cause of the fatty build-up is not known although the stages of progression are well described, and certain risk factors well-identified, such as smoking, high cholesterol levels, obesity, diabetes etc. More recently, evidence has pointed to a potential infectious cause of atherosclerotic vascular disease. Cytomegalo virus, Chlamydia and Helicobacter pylori have all been associated with atherosclerotic disease. The infectious pathogens are presumed to cause chronic inflammation, which results in atherosclerotic deposition.
In one study involving Helicobacter pylori, 38 atherosclerotic plaques were obtained at carotid endocardectomy, and examined for the presence or absence of bacteria. The researchers used morphological and immunohistochemical techniques to do this, and a highly sensitive polymerase chain reaction method to search for Helicobacter DNA. As a control, the researchers examined 7 carotid arteries obtained at autopsy from subjects without carotid atherosclerosis. The researchers detected the presence of Helicobacter pylori DNA in 20 out of 38 atheromatous plaques, and morphological/immunohistochemical evidence of bacteria in 10 of the DNA-positive plaques. None of the 7 normal carotid arteries were positive for Helicobacter pylori (Ameriso, 2001).
If atherosclerotic artery disease were to be infectious in etiology, antibiotics probably would not work well due to lack of penetration into dense plaque.
In view of these and other deficiencies of the prior art it is the primary object of the present invention to provide an apparatus and method for treating atherosclerotic vascular disease using light radiation.
Another more specific object is to treat vascular disease of the character described using light radiation without significant damage to the vessel or surrounding body tissue.
A further object of the present invention is to provide an apparatus of the type described which is characterized by emitting radiation which is destructive to pathogenic microorganisms that cause and/or contribute to atherosclerotic disease without producing sufficient heat to damage body tissues.
Yet another object of the invention is to provide an apparatus of the character described which is small enough for insertion into relatively small blood vessels such as the coronary arteries but is also useful for treating blood vessels throughout the body including cerebral vessels and peripheral vessels that are partially or completely occluded by atherosclerotic plaque.
REFERENCES:
patent: 4773899 (1988-09-01), Spears
patent: 4848336 (1989-07-01), Fox et al.
patent: 4998930 (1991-03-01), Lundahl
patent: 5041108 (1991-08-01), Fox et al.
patent: 5059191 (1991-10-01), Beyer et al.
patent: 5188632 (1993-02-01), Goldenberg
patent: 5334171 (1994-08-01), Kaldany
patent: 5405369 (1995-04-01), Selman et al.
patent: 5531662 (1996-07-01), Carr
patent: 5591199 (1997-01-01), Porter et al.
patent: 5637877 (1997-06-01), Sinofsky
patent: 5647840 (1997-07-01), D'Amelio et al.
patent: 5653683 (1997-08-01), D'Andrea
patent: 5741246 (1998-04-01), Prescott
patent: 5769844 (1998-06-01), Ghaffari
patent: 5843143 (1998-12-01), Whitehurst
patent: 5845640 (1998-12-01), Lawandy
patent: 5855595 (1999-01-01), Fujishima et al.
patent: 5871522 (1999-02-01), Sentilles
patent: 5989283 (1999-11-01), Wilkens
patent: 6061591 (2000-05-01), Freitag et al.
patent: 6070096 (2000-05-01), Hayashi
patent: 10-94583 (1998-04-01), None
U.S. patent application Ser. No. 09/338,687, Ganz.
U.S. patent application Ser. No. 09/598,653, Ganz.
U.S. patent application Ser. No. 10/119,976, Ganz et al.
C.E. Millson et al., Ex-Vivo Treatment of Gastric Helico-bacter Infection by Photodynamic Therapy; Journal of Photo-chemistry and Photobiology B: Biology 32 (1996) 59-65 London.
C.E. Millson et al., The Killing of Helicobacter pylori by Low Power Laser Light in the Presence of a Photosensitizer; J Med Microbiology vol. 44 (1996) 245-252.
Martinetto P., et al. Bactercidal Effects Induced by Laser Irradiation and Haematoporphyrin Against Gram-positive and Gram-negative Microorganisms. Drugs Exp. Clin Res. XII (4): 335-342, 1986.
Kubey W., et al. In Vitro Studies on the Microbicidal Effectiveness of a Xenon-based Ultraviolet Light Device for Continuous Ambulatory Peritoneal Connections. Blood Purif. 9 (2): 102-108, 1991.
Harmon James V.
Peffley Michael
LandOfFree
Apparatus and method for treating atherosclerotic vascular... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apparatus and method for treating atherosclerotic vascular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apparatus and method for treating atherosclerotic vascular... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3205890